Effectiveness of Risankizumab in Crohn's Disease, our real-world experience: Clinical, Biochemical and Ultrasonographic responses. A single centre, observational, retrospective study

被引：0
|
作者：
Lozano, O. Moralejo [1 ]
Pesantes, V. C. Jarrin [1 ]
Tercero, M. Abanades [1 ]
Perez, L. Ruano [1 ]
Luque, R. Salmoral [1 ]
Rosas, C. Munoz [1 ]
Rodriguez, R. A. Gomez [1 ]
机构：
[1] Hosp Univ Toledo, Gastroenterol & Hepatol Dept, Toledo, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1274
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1100
引用
收藏
页码：i2025 / i2026
页数：2
相关论文
共 50 条
  • [1] Real-world effectiveness and safety of Risankizumab in Crohn's Disease
    Mcshane, C.
    Olivera Sendra, P. A.
    Kim, J.
    Milgrom, R.
    Stempak, J.
    Nguyen, G.
    Weizman, A., V
    Croitoru, K.
    Gallinger, Z.
    Huang, V
    Steinhart, H.
    Targownik, L.
    Lee, S. H.
    Silverberg, M.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I2023 - I2024
  • [2] A MULTICENTER STUDY OF THE REAL-WORLD EFFECTIVENESS AND SAFETY OF RISANKIZUMAB IN CROHN'S DISEASE
    Askar, Manar
    Belani, Seema
    Devi, Jalpa
    Huang, Katherine
    Khan, Abdul
    Said, Hyder
    Patel, Anish
    Bishu, Shrinivas
    Shukla, Richa
    Fenster, Marc
    Ungaro, Ryan C.
    Yarur, Andres
    Deepak, Parakkal
    Johnson, Amanda M.
    GASTROENTEROLOGY, 2024, 166 (05) : S1143 - S1144
  • [3] P0832 Real-world effectiveness of risankizumab in Crohn's Disease: The UK Experience
    Elford, A.
    Plevris, N.
    Constantine-Cooke, N.
    Shah, K.
    Faloon, S.
    Colwill, M.
    Akbani, U.
    Morgan, H.
    Ghoda, A.
    Radia, C.
    Young, D.
    Morris, S.
    Anwar-Hashim, Z.
    Hassall, J.
    Thomas, M.
    Dyall, L.
    Clough, J.
    Mahmood, T.
    Mohammed, A.
    Rudling, R.
    Dhar, A.
    Gaya, D.
    Verma, A.
    Seenan, J.
    Johnston, E.
    Goel, R.
    Hicks, L.
    Sebastian, S.
    Hale, M.
    Harvey, P.
    Cooney, R.
    Cummings, F.
    Kent, A.
    King, A.
    Limdi, J.
    Sellinger, C.
    Pollok, R.
    Parkes, G.
    Lees, C.
    PAN UK Risankizumab CD Study Grp
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1589 - i1591
  • [4] Effectiveness of risankizumab in moderate-to-severe Crohn's Disease: A Canadian multicentric real-world study
    Zoughlami, A.
    Abbas, A.
    Almushir, S.
    Zeghal, M.
    Khan, N. S.
    Milgrom, R.
    Daher, S.
    Mccurdy, J. D.
    Narula, N.
    Rosenfeld, G.
    Silverberg, M. S.
    Lakatos, P. L.
    Bessissow, T.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1819 - i1819
  • [5] REAL WORLD EXPERIENCE: CLINICAL OUTCOMES AFTER RISANKIZUMAB INDUCTION FOR CROHN'S DISEASE
    Sauk, Jenny S.
    Keyashian, Kian
    Parian, Alyssa M.
    Limsui, David
    Nayeb-Hashemi, Hamed
    Briggs, Kristi
    Kim, Sowon
    Yin, Xiaoxiao
    Trujillo, Sophie
    Chowdhury, Reezwana
    Sharma, Sowmya
    Ho, Andrew
    Park, Sunhee
    Lazarev, Mark
    Limketkai, Berkeley N.
    GASTROENTEROLOGY, 2024, 166 (05) : S1149 - S1149
  • [6] Effectiveness and Safety of Risankizumab Induction Therapy in Crohn's Disease: Prospective Real-World Experience in a Large Tertiary Center
    Zinger, Adar
    Choi, David K.
    Choi, Natalie K.
    Garcia, Nicole M.
    Cohen, Russell D.
    Dalal, Sushila
    Cleveland, Noa Krugliak
    Rubin, David T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S834 - S834
  • [7] Short-term effectiveness of risankizumab in patients with Crohn<acute accent>s Disease: Experience in our centre
    Delgado, T. Valdes
    Gallardo, M. Rodriguez
    Perez, B. Maldonado
    Jimenez, M. Belvis
    Laria, L. Castro
    Arias, F. Arguelles
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1242 - i1244
  • [8] Switching from Ustekinumab to Risankizumab Improves Outcomes in Crohn's Disease: A Single-Centre Real-World Data Analysis
    Qazi, U.
    Padley, J.
    Colwill, M.
    Mehta, S.
    Donovan, F.
    Alves, A. M. Francisco
    Pollok, R.
    Poullis, A.
    Patel, K.
    Honap, S.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2012 - i2012
  • [9] Risankizumab Effectiveness and Safety in Crohn's Disease: Real-world Data From a Large Tertiary Center
    Zinger, Adar
    Choi, David
    Choi, Natalie
    Cohen, Russell D.
    Rubin, David T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (06) : 1336 - 1338
  • [10] Real-world effectiveness of upadacitinib in Crohn's disease; a UK multicentre retrospective cohort study
    Elford, A.
    Bishara, M.
    Plevris, N.
    Gros, B.
    Constantine-Cooke, N.
    Goodhand, J.
    Kennedy, N.
    Ahmad, T.
    Lees, C.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1523 - I1525
12345